Search

Your search keyword '"Erika Nakatsuka"' showing total 35 results

Search Constraints

Start Over You searched for: Author "Erika Nakatsuka" Remove constraint Author: "Erika Nakatsuka"
35 results on '"Erika Nakatsuka"'

Search Results

1. Characterization of DNA damage repair pathway utilization in high-grade serous ovarian cancers yields rational therapeutic approaches

2. Placenta previa with posterior extrauterine adhesion: clinical features and management practice

3. Conservative management for adherent placenta after live birth in angular or interstitial pregnancies: A new entity 'angular placenta attachment'

4. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells

5. Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types

6. Effect of Japanese Kampo Medicine Therapy for Menopausal Symptoms after Treatment of Gynecological Malignancy

7. Interleukin 6 receptor is an independent prognostic factor and a potential therapeutic target of ovarian cancer.

8. Data from Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells

9. Supplementary Figure 1 - 6, Table 1 from Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells

10. Conservative management for adherent placenta after live birth in angular or interstitial pregnancies: A new entity 'angular placenta attachment'

11. Endometrial galectin-3 causes endometriosis by supporting eutopic endometrial cell survival and engraftment in the peritoneal cavity

12. Placenta previa with posterior extrauterine adhesion: clinical features and management practice

13. Downregulation of miR-194-5p induces paclitaxel resistance in ovarian cancer cells by altering MDM2 expression

14. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells

15. Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene

16. Plasminogen activator inhibitor-1 is an independent prognostic factor of ovarian cancer and IMD-4482, a novel plasminogen activator inhibitor-1 inhibitor, inhibits ovarian cancer peritoneal dissemination

17. Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells

18. The Novel IκB Kinase β Inhibitor, IMD-0560, Has Potent Therapeutic Efficacy in Ovarian Cancer Xenograft Model Mice

19. Angular placenta attachment: a new entity of adherent placenta after live birth in angular or interstitial pregnancies

20. Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types

21. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma

22. Efficacy of the dedicated needle for uterine compression suture and Bakri balloon for postpartum hemorrhage with placenta previa

23. Abstract 2585: The development of a novel microRNA replacement therapy for ovarian cancer - a potential of patient derived-exosomes as a carrier

25. Septic shock by Group A streptococcal infection that developed after the harvesting procedure for endometrial cytology: Report of two cases

26. Clinical relevance of circulating cell-free microRNAs in ovarian cancer

27. Abstract 505: Low miR-522 expression is correlated with paclitaxel resistance in ovarian cancer cells

28. Targeting Inhibitor of κB Kinase β Prevents Inflammation-Induced Preterm Delivery by Inhibiting IL-6 Production from Amniotic Cells

29. Abstract 4655: Elevated level of serum miR-99a is correlated with serous epithelial ovarian cancer and can be a potential biomarker

30. Interleukin 6 receptor is an independent prognostic factor and a potential therapeutic target of ovarian cancer

31. Abstract 1579: Exosomes promote ovarian cancer invasion through CD-44 transfer to mesothelial cells

32. Abstract 3121: Hypoxia-related microRNA, miR-199a-3p, displays tumor suppressor function in ovarian cancer

33. Abstract 5060: Exosome transfer from ovarian cancer cells to mesothelial cells promotes cell invasion by upregulating MMP-9 secretion and increasing clearance of mesothelial cells

34. Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene.

35. Clinical relevance of circulating cell-free microRNAs in ovarian cancer.

Catalog

Books, media, physical & digital resources